Table of Content

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations

3. Market Determinants
3.1. Motivators
3.1.1. Rising Prevalence of Gynecological Cancers
3.1.2. Rising Initiatives for Women Health
3.1.3. Government and Private Organizations Support for Development of Novel Drugs for Gynecological Cancer
3.1.4. Strong Pipeline for Drugs
3.2. Restraints
3.2.1. High Costs of Treatment
3.2.2. Lack of Reimbursement Policies in Under-Developed Countries
3.2.3. Low Awareness Among Developing Countries Population
3.3. Opportunities
3.3.1. Extensive R&D and Drug Discovery
3.3.2. Emerging Markets in Emerging Economies

4. Market Segmentation
4.1. Global Gynecological Cancer Market by Type
4.1.1. Cervical Cancer
4.1.2. Ovarian Cancer
4.1.3. Uterine Cancer
4.1.4. Vaginal Cancer
4.1.5. Vulvar Cancer
4.1.6. Others (Fallopian Tube Cancer)
4.2. Global Gynecological Cancer Market by Diagnosis
4.2.1. Colposcopy
4.2.2. Biopsy test
4.2.3. Human papillomavirus (HPV) tests
4.2.4. Imaging test
4.2.4.1. Intravenous Urography
4.2.4.2. Positron Emission Tomography (PET Scan)
4.2.4.3. Computed Tomography (CT)
4.2.4.4. Magnetic Resonance Imaging (MRI)
4.2.4.5. Others
4.2.5. Others (Pelvic Test)
4.3. Global Gynecological Cancer Market by Therapeutic Modality
4.3.1. Chemotherapy
4.3.2. Radiation Therapy
4.3.3. Hormonal Therapy
4.3.4. Immunotherapy
4.4. Global Gynecological Cancer Market by End-Users
4.4.1. Hospitals and Surgical Centres
4.4.2. Diagnostic Centres
4.4.3. Others (Research Institutions)

5. Competitive Landscape
5.1. Key Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AstraZeneca, PLC
7.3. Becton, Dickinson and Co.
7.4. Boehringer Ingelheim GmbH
7.5. Bristol Myers Squibb Co.
7.6. Caris Life Sciences, Inc.
7.7. Eli Lilly and Co.
7.8. F. Hoffmann-La Roche, Ltd.
7.9. Genentech, Inc.
7.10. GlaxoSmithKline PLC
7.11. Hologic, Inc.
7.12. Janssen Pharmaceuticals, Inc.
7.13. Kazia Therapeutics, Ltd.
7.14. Merck & Co., Inc.
7.15. NuCana PLC
7.16. Pfizer, Inc.
7.17. Sanofi S.A.
7.18. Siemens Healthcare GmbH
7.19. Takeda Pharmaceuticals Co., Ltd.
7.20. Teva Pharmaceuticals, Ltd.



List of Figures


FIGURE # 1 GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY CANCER TYPE, 2017-2023 (%)
FIGURE # 2 GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY DIAGNOSIS, 2017-2023 (%)
FIGURE # 3 GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY THERAPEUTIC MODALITY, 2017-2023 (%)
FIGURE # 4 GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY END-USERS, 2017-2023 (%)
FIGURE # 5 GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY GEOGRAPHY, 2017-2023 (%)
FIGURE # 6 NORTH AMERICA GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UNITED STATES GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 CANADA GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 EUROPE GYNECOLOGICAL CANCER S MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 UK GYNECOLOGICAL CANCER S MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 FRANCE GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 SPAIN GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 GERMANY GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 ITALY GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 ROE GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 INDIA GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 CHINA GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 JAPAN GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 20 REST OF ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 21 REST OF THE WORLD GYNECOLOGICAL CANCER MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLIONS)
TABLE # 2 GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL CERVICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL OVARIAN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL UTERINE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL VAGINAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL VULVAR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL OTHER GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL COLPOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL BIOPSY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL IMAGING TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL HUMAN PAPILLOMAVIRUS TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL OTHER TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, BY THERAPEUTIC MODALITY 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL HORMONAL THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 20 GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 21 GLOBAL HOSPITALS AND SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 22 GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 23 GLOBAL OTHERS GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 24 NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 25 NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 26 NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2017-2023 ($ MILLION)
TABLE # 27 NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 28 NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 29 EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 30 EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 31 EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2017-2023 ($ MILLION)
TABLE # 32 EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 33 EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 34 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 35 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 36 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2017-2023 ($ MILLION)
TABLE # 37 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 38 ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 39 REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 40 REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
TABLE # 41 REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2017-2023 ($ MILLION)
TABLE # 42 REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)